Back to the Future: The Recurring Shortage of Generic Cancer Drugs
(And how survey research has helped give a voice to the problem)
DEJA-VU ALL OVER AGAIN
It is exasperating to see us, once again, running short of old drugs that – despite an expanding armamentarium of exciting, advanced therapies – continue to be backbone treatment for many types of cancers. There is no small irony in the fact that the world’s richest economy cannot figure out a way to supply (at any price) nominally cheap, life-extending drugs to all the people who need them – an incontestable truth that should make us all wince.
Download PDF to Learn More.
Learn More
This article was published in the Summer of 2026
